| scholarly article | Q13442814 |
| P50 | author | Yuri V Bobryshev | Q88065781 |
| Igor A. Sobenin | Q38323510 | ||
| Veronika A. Myasoedova | Q40442654 | ||
| Paolo Poggio | Q41885090 | ||
| Alexander Orekhov | Q51464003 | ||
| P2093 | author name string | Alexandra A Melnichenko | |
| Varvara A Orekhova | |||
| Tatyana V Kirichenko | |||
| Alessio Ravani | |||
| P2860 | cites work | Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 |
| Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II) | Q28193306 | ||
| Effects of phytoestrogens derived from soy bean on expression of adhesion molecules on HUVEC | Q28252582 | ||
| Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group | Q29615228 | ||
| Cross-sectional analysis of baseline data to identify the major determinants of carotid intima-media thickness in a European population: the IMPROVE study | Q33516999 | ||
| Genistein supplementation inhibits atherosclerosis with stabilization of the lesions in hypercholesterolemic rabbits | Q33629657 | ||
| A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy | Q34245107 | ||
| Effects of phytoestrogens derived from red clover on atherogenic adhesion molecules in human endothelial cells. | Q34591723 | ||
| Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis | Q34604937 | ||
| The phytoestrogens Genistein and Daidzein, and 17 beta-estradiol inhibit development of neointima in aortas from male and female rabbits in vitro after injury | Q73276079 | ||
| Effect of resveratrol on intimal hyperplasia after endothelial denudation in an experimental rabbit model | Q73470880 | ||
| Phytoestrogen derivatives differentially inhibit arterial neointimal proliferation in a mouse model | Q80207030 | ||
| Raloxifene slows down the progression of intima-media thickness in postmenopausal women | Q80712498 | ||
| Transforming growth factor activity is a key determinant for the effect of estradiol on fatty streak deposit in hypercholesterolemic mice | Q80776303 | ||
| 17β-estradiol promotes cholesterol efflux from vascular smooth muscle cells through a liver X receptor α-dependent pathway | Q87049239 | ||
| Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. | Q34615300 | ||
| Menopause and cardiovascular risk. | Q35298030 | ||
| Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: a randomized controlled trial | Q35449373 | ||
| Endothelial-dependent vasodilation and incidence of type 2 diabetes in a population of healthy postmenopausal women | Q36056443 | ||
| Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol | Q37038435 | ||
| Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: summary and discussion of the American Society of Echocardiography consensus statement | Q37419330 | ||
| Oral antidiabetic agents: anti-atherosclerotic properties beyond glucose lowering? | Q37597253 | ||
| Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials | Q37658616 | ||
| The pharmacogenomics of sex hormone metabolism: breast cancer risk in menopausal hormone therapy | Q38003702 | ||
| Hormone therapy and breast cancer risk 10 years after the WHI. | Q38011782 | ||
| Effect of statin therapy on the progression of common carotid artery intima-media thickness: an updated systematic review and meta-analysis of randomized controlled trials | Q38055275 | ||
| Blood atherogenicity as a target for anti-atherosclerotic therapy | Q38084458 | ||
| Carotid atherosclerotic plaque stenosis: the stabilizing role of statins | Q38251322 | ||
| Impact of acarbose on carotid intima-media thickness in patients with newly diagnosed impaired glucose tolerance or mild type 2 diabetes mellitus: A one-year, prospective, randomized, open-label, parallel-group study in Japanese adults with establis | Q38498458 | ||
| Phytoestrogen-Rich Dietary Supplements in Anti-Atherosclerotic Therapy in Postmenopausal Women | Q38631531 | ||
| ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease | Q39312485 | ||
| Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. | Q40882910 | ||
| New models for predicting cardiovascular events | Q41032917 | ||
| The soyabean isoflavone genistein modulates endothelial cell behaviour | Q42467900 | ||
| Estradiol regulates monocyte chemotactic protein-1 in human coronary artery smooth muscle cells: a mechanism for its antiatherogenic effect | Q42507179 | ||
| Phytoestrogen α-Zearalanol attenuates homocysteine-induced apoptosis in human umbilical vein endothelial cells | Q42936985 | ||
| Genistein, a potent inhibitor of secretory phospholipase A2: a new insight in down regulation of inflammation | Q43247374 | ||
| Antiobesity action of a daidzein derivative on male obese mice induced by a high-fat diet | Q43255532 | ||
| Increased prostacyclin synthesis by atherosclerotic arteries from estrogen-treated monkeys | Q43679636 | ||
| The interaction of resveratrol with ferrylmyoglobin and peroxynitrite; protection against LDL oxidation. | Q44103104 | ||
| Effects of flavonoids on the susceptibility of low-density lipoprotein to oxidative modification | Q44524051 | ||
| Rates and determinants of site-specific progression of carotid artery intima-media thickness: the carotid atherosclerosis progression study | Q44970486 | ||
| Hormone therapy impairs endothelial function in postmenopausal women with type 2 diabetes mellitus treated with rosiglitazone | Q45050650 | ||
| The Blatt-Kupperman menopausal index: a critique | Q45220981 | ||
| Genistein inhibits proliferation and functions of hypertrophic scar fibroblasts | Q46270343 | ||
| KEEPS: The Kronos Early Estrogen Prevention Study | Q46417155 | ||
| Revealing anti-inflammatory mechanisms of soy isoflavones by flow: modulation of leukocyte-endothelial cell interactions | Q46417506 | ||
| Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels. | Q46687045 | ||
| Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. | Q50595888 | ||
| Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. | Q50647592 | ||
| Effects of glimepiride and glibenclamide on carotid atherosclerosis in type 2 diabetic patients. | Q51157658 | ||
| Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. | Q55053962 | ||
| Carotid intima-media thickness by B-mode ultrasound as surrogate of coronary atherosclerosis: correlation with quantitative coronary angiography and coronary intravascular ultrasound findings | Q57398791 | ||
| Attenuation of Atherogenesis via the Anti-inflammatory Effects of the Selective Estrogen Receptor Beta Modulator 8β-VE2 | Q58657358 | ||
| Endothelial function affects early carotid atherosclerosis progression in hypertensive postmenopausal women | Q58919623 | ||
| Anti-atherosclerotic therapy based on botanicals | Q59467914 | ||
| Phytoestrogens and Lipoproteins in Women | Q61070448 | ||
| Antiatherogenic effect of grape flavonoids in an ex vivo model | Q61707611 | ||
| A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins | Q73052416 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P577 | publication date | 2016-08-11 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Anti-Atherosclerotic Effects of a Phytoestrogen-Rich Herbal Preparation in Postmenopausal Women | |
| P478 | volume | 17 |
| Q90189405 | Carotid Atherosclerosis Progression in Postmenopausal Women Receiving a Mixed Phytoestrogen Regimen: Plausible Parallels with Kronos Early Estrogen Replacement Study |
| Q93164892 | Medicinal Plants as a Potential and Successful Treatment Option in the Context of Atherosclerosis |
| Q47558998 | Phytoestrogen-Rich Natural Preparation for Treatment of Climacteric Syndrome and Atherosclerosis Prevention in Perimenopausal Women. |
| Q99611339 | Sophoricoside Ameliorates Cardiac Hypertrophy by activating AMPK/mTORC1-mediated autophagy |
| Q38611119 | Soy Improves Cardiometabolic Health and Cecal Microbiota in Female Low-Fit Rats |
| Q89895473 | Targeting Abdominal Obesity and Its Complications with Dietary Phytoestrogens |
| Q92673154 | The Role of Dietary Phytoestrogens and the Nuclear Receptor PPARγ in Adipogenesis: An in Vitro Study |
| Q52654072 | Therapeutic Perspectives of 8-Prenylnaringenin, a Potent Phytoestrogen from Hops. |
| Q91192954 | Therapeutic effects of garlic in cardiovascular atherosclerotic disease |
Search more.